Continuous bioreactors & perfusion culture
Bioreactors that feed fresh medium and remove product continuously while keeping the cells in — replacing batch manufacturing, commercially mature in perfusion culture, with reported productivity gains of 400–500 %.
1 · What it gives
A continuous bioreactor supports continuous cell culture and product formation: fresh medium is added and spent medium and product removed while the cells are retained. Continuous bioprocessing replaces traditional batch manufacturing. Continuous perfusion cell culture is commercially mature, with implementations in use since at least 2015. Integrated continuous bioprocessing is reported to give productivity gains of 400–500 % and cost reductions of about 15 % against batch.
2 · What it replaces 6
3 · How to implement 5 steps
- 1InoculumPrepare the inoculum.
- 2Single-use bioreactorTransfer the inoculum to a single-use bioreactor.
- 3Perfusion cultureRun perfusion culture with continuous media exchange.
- 4Harvest with cell retentionHarvest the product continuously while retaining the cells.
- 5Continuous downstreamFeed the harvest to automated continuous downstream processing.
4 · Who delivers
Matched suppliers (matched automatically)
| Avani | Indonesia | Producer | active |
| BIONET | Spain | Services / consulting | active |
| Accra Compost and Recycling Plant Limited | Ghana | Producer | active |
| Benur Top Group | Indonesia | Producer | active |
| BioTerra | Uruguay | Services / consulting | active |
| Blue Aqua International | Singapore | Distributor | active |
| INORA Biotech Pvt. Ltd. | India | Producer | active |
| COOPEVICTORIA | Costa Rica | Services / consulting | active |
| Pyrogreen Energy | China | Producer | active |
| Thermo Fisher Scientific | United States | Producer | active |
| Sanergy | Kenya | Services / consulting | active |
| Aristogene Biosciences Pvt. Ltd. | India | Producer | active |
Leading companies and institutes (from the brief)
Providers of continuous bioprocessing systems named in the sources: Sartorius, GE Healthcare, Novasep, Tarpon and Semba Biosciences. Further equipment makers are matched by the portal under Bioprocess equipment and Biomanufacturing.
5 · Rules & route to market
none for the service; operator permits (integrated environmental permit ~1 month)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US FDA and the ICH provide guidance and oversight; the sources cite ICH Q9 on quality risk management. Regulatory uncertainty for integrated continuous processes remains a listed risk.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
The sources reviewed on 2026-10-16 identified no China regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
6 · Money: tenders & grants
| Grant | Advancing bio-printing of living cells for regenerative medicine European Commission · EU | Sep 22, 2027 341 days |
| Grant | Capacity building for extending product lifecycles through repair and refurbishment European Commission · EU | Sep 22, 2027 341 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 174 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 341 days |
| Grant | Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU | Feb 2, 2027 109 days |
7 · Tech stack & innovations
Main risks from the sources: regulatory uncertainty, technology gaps in integrating the steps into one process, and material robustness of single-use equipment.
Sources 5
- Cell.com — www.cell.com 2026-10-16
- Doi.org — doi.org 2026-10-16
- Tsapps.nist.gov — tsapps.nist.gov 2026-10-16
- Doi.org — doi.org 2026-10-16
- Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16